Q4 2025 Earnings Call February 9, 2026 8:30 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra ...
Waters Corporation (NYSE:WAT) Q4 2025 Earnings Call Transcript February 9, 2026 Waters Corporation beats earnings ...
Earnings call Waters Corporation reported 7% revenue growth and 11% adjusted EPS growth for FY2025, ending the year with strong Q4 performance. The company completed its acquisition of BD's ...
aMedical Research Council-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban 4001, South Africa The ...
Background Prevention of hospital-acquired infections (HAI) is central to providing safe and high quality healthcare. Transmission of infection between patients by health workers, and the irrational ...
Background/Aims To analyse patients with chronic ocular graft-versus-host disease (GvHD) under treatment with 100% autologous serum eye drops from a sealed manufacturing system. Methods 17 patients ...
Waters (NYSE:WAT) executives said the company closed out 2025 with a “strong finish” and entered 2026 with a major portfolio ...
Waters Corporation (WAT) reported its fourth-quarter 2025 earnings, showcasing a slight beat in both earnings per share (EPS) and revenue. The company posted an adjusted EPS of $4.53, surpassing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results